AG
Artal Group Portfolio holdings
AUM
$930M
This Quarter Return
-25.15%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$2.37B
AUM Growth
+$2.37B
(-30%)
Cap. Flow
-$36.4M
Cap. Flow
% of AUM
-1.54%
Top 10 Holdings %
Top 10 Hldgs %
48.11%
Holding
156
New
7
Increased
9
Reduced
11
Closed
16
Top Buys
| 1 |
argenx
ARGX
|
$27.6M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$21.6M |
| 3 |
IGMS
IGM Biosciences
IGMS
|
$13.4M |
| 4 |
Apellis Pharmaceuticals
APLS
|
$10.2M |
| 5 |
VIGL
Vigil Neuroscience
VIGL
|
$7.88M |
Top Sells
| 1 |
Amicus Therapeutics
FOLD
|
$18.9M |
| 2 |
NovaGold Resources
NG
|
$17.8M |
| 3 |
ALBO
Albireo Pharma, Inc. Common Stock
ALBO
|
$14M |
| 4 |
Krystal Biotech
KRYS
|
$13.3M |
| 5 |
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
|
$11.9M |
Sector Composition
| 1 | Healthcare | 91.85% |
| 2 | Consumer Discretionary | 6.7% |
| 3 | Financials | 0.57% |
| 4 | Consumer Staples | 0.32% |
| 5 | Industrials | 0.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
iQIYI
IQ
$2.61B
| – | – |
-1,000,000
| Closed | -$4.56M |
|
152
Intel
INTC
$105B
| – | – |
0
| – | – |
|
153
GDS Holdings
GDS
$6.54B
| – | – |
-100,000
| Closed | -$4.72M |
|
154
dLocal
DLO
$4.09B
| – | – |
-20,000
| Closed | -$714K |
|
155
Citigroup
C
$175B
| – | – |
0
| – | – |
|
156
Bristol-Myers Squibb
BMY
$96.7B
| – | – |
0
| – | – |
|